Liver cirrhosis is the result of long-term liver damage — commonly due to chronic hepatitis, alcohol-related liver disease, non-alcoholic fatty liver disease (NAFLD/NASH), or autoimmune conditions — leading to scarring that impairs liver function. Established scar tissue is generally not reversible with any currently available treatment, including stem cell therapy. Standard care focuses on treating the underlying cause, managing complications, and, for decompensated cirrhosis, evaluating patients for liver transplantation. Stem Cell Cure India offers an evaluation to help patients understand whether stem cell therapy may be relevant to their specific case, always alongside — never instead of — hepatology care.
For patients with compensated cirrhosis who are not yet candidates for transplant, or who want to explore options alongside their ongoing hepatology care, some look into regenerative approaches such as stem cell therapy as an additional avenue to discuss with a specialist.
Dr. Tyagi leads regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for patients being evaluated for liver and other regenerative conditions.
Dr. Singh brings over three decades of clinical experience in general medicine and surgery, supporting the overall health evaluation of patients before and during their stem cell therapy journey.
Mesenchymal Stem Cells (MSCs) are being studied for their potential anti-inflammatory and antifibrotic effects, and for a possible role in supporting liver function in some studies of chronic liver disease. It is important to set realistic expectations: established cirrhotic scarring is not currently known to be reversed by this or any other available treatment, and stem cell therapy is not a substitute for liver transplant evaluation in decompensated disease. This approach is explored as a complement to — not a replacement for — standard hepatology management of the underlying cause and its complications.
Suitability depends on the cause and stage of liver disease, and whether any complications are present. Before travelling, our team reviews:
No. Established cirrhotic scarring is generally considered permanent, and stem cell therapy is not a cure. It is explored as an option that may help support liver function, alongside standard hepatology care for the underlying cause.
No. For decompensated cirrhosis, liver transplant evaluation by a hepatologist is the standard of care, and stem cell therapy should not be considered a substitute. Please continue any transplant work-up already underway.
Recent liver function tests, Child-Pugh/MELD score if available, ultrasound or FibroScan report, viral hepatitis panel, and details of any complications.
Most patients stay between 7 and 10 days, depending on the diagnostic work-up and treatment plan required.
Yes. Once an evaluation is confirmed, we provide the invitation and supporting documents needed to apply for a Medical Visa.
Cost depends on the specific condition, its severity, and the plan required. Contact us for a personalised quote after sharing your reports and medical history.
Source: These are real, verified Google reviews currently published on stemcellcure.in — pulled from our Google Business Profile (5.0★, 33+ reviews).
Contact Stem Cell Cure India today to share your medical history and get a personalised opinion on suitability.
